In vivo, the conjugates of those GRP78-targeting peptides to liposomes with (188)Re yielded significantly greater uptake of (188)Re by the breast cancer xenografts as compared with the peptide-free (188)Re-liposomes [224]. This evidence concerns the gene HSPA5 and breast carcinoma.